CCRM
Mediya Safarinasab is an experienced professional in the biomedical engineering field with a strong background in validation and operations roles. Currently serving as a Validation Associate II at CCRM since January 2022, Mediya's previous positions include Operations Associate I, Hospital Ward Clerk at Arman International Hospital, and Operations Associate in the Cell and Gene Therapy Department at Gandhi Hotel-Hospital. Mediya's experience spans various responsibilities, including managing medical records, coordinating patient care, executing project tasks related to lab operations, and ensuring compliance with GMP regulations. Mediya holds a Master's degree in Biomedical Engineering from the University of Ottawa and a Bachelor's degree in Biomedical Engineering with a focus on Biomaterials from SRBIAU.
This person is not in any offices
CCRM
1 followers
Regenerative Medicine (RM), which aims to harness the power of stem cells, biomaterials and molecules to repair, regenerate or replace diseased cells, tissues and organs, has the promise to treat, manage and perhaps cure some of the most devastating and costly diseases in the world today. Many new and potentially life-changing RM-based treatments never reach patients because they are not successfully moved from the laboratory to a stage where they can be used in medicine. In order to fulfill RM’s promise to treat the many diseases affecting our population, a world-renowned group of stem cell scientists and engineers have come together to form CCRM, a leader in developing and commercializing regenerative medicine and cell therapy technologies. CCRM formally launched on June 14, 2011. CCRM supports the development and commercialization of regenerative medicines and associated enabling technologies, with a specific focus on cell and gene therapy.